Pfizer Inc. Canadian Depositary Receipt (PFE)

Profile

https://www.pfizer.com

Pfizer Inc. Canadian Depositary Receipt is an equity security that provides Canadian investors with fractional economic exposure to Pfizer Inc., one of the world’s largest research‑based pharmaceutical companies. The receipt represents an interest in Pfizer shares while trading in Canadian dollars, with a built‑in currency hedge designed to reduce the impact of fluctuations between the U.S. and Canadian dollars. Through this structure, investors gain access to Pfizer’s diversified portfolio of prescription medicines and vaccines across therapeutic areas such as oncology, cardiology, immunology, and infectious diseases. The Canadian Depositary Receipt passes through dividends from the underlying Pfizer shares, typically on a quarterly basis, reflecting the company’s established dividend‑paying profile. By combining blue‑chip pharmaceutical exposure with local‑currency trading and fractional share accessibility, Pfizer Inc. Canadian Depositary Receipt plays a role in facilitating cross‑border healthcare sector investment within the Canadian market.